Co-treatment with resveratrol significantly suppressed the TNF-β-induced activation of NF-κB and the downstream targets (MMP-9 and CXCR4), resulting in the inhibition of cancer cell migration and CSC formation [118]. The gene discussed is NFKB1; the disease is cancer.